1
0
0
(1 - 14 von 14
)
Abstracts - American Epilepsy Societyaesnet.org › abstractslisting › lacosamide-added-to-a...
www.aesnet.org
Author(s): Uwe Runge, Thomas Mayer, Matthias Noack - Rink, Francisco Ramirez, Marc De Backer, Frank Tennigkeit and Konrad Werhahn.
EB | Epilepsy & Behavior | Vol 48, Pages (July 2015) |...
www.sciencedirect.com
Eugen Trinka, Günter Krämer, Konrad Werhahn. Pages : Download PDF. select article Response to “Vascular Precursor Epilepsy — Old wine in new skins?”.
Konrad J Werhahn – ScienceOpen
www.scienceopen.com
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Authors: Melissa Brock, Marc De Backer, Konrad Werhahn … A randomized, double-blind comparison of antiepileptic ...
Epilepsy Foundation Pipeline Conference – Bristol Epilepsy...
bristolepilepsysite.wordpress.com
Every two years, the Epilepsy Foundation of America, holds its Pipeline Conference to bring together decision-makers with a stake in the field of epilepsy...
VIDEO Epilepsy Pipeline Conference - Day 2 - EPILESSIA NEL MONDO...
epilessia-info.forumfree.it
This year’s Pipeline Conference will take place February , 2018, at the Westin St. Francis hotel in San Francisco, California
Konrad J. Werhahn
www.infona.pl
Intracortical disinhibitory mechanisms play a crucial role in epilepsy. Therefore, the recruitment of motor cortical excitability was evaluated to ...
Vascular precursor epilepsy - Old wine in new skins? - PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Authors. Eugen Trinka , Günter Krämer , Konrad Werhahn. Affiliations. 1 Department of Neurology, Paracelsus Medical University, Christian Doppler Klinik ...
Efficacy and tolerability of lacosamide monotherapy in elderly...
n.neurology.org
Konrad Werhahn, Felix Rosenow, Manuel Toledo, et al. April 17, April 27, Efficacy of lacosamide monotherapy in patients with newly diagnosed epilepsy stratified by baseline disease severity: sub-analysis of data from a prospective non-inferiority trial versus controlled-release carbamazepine (P5.227).
UCB showcases commitment to treatment and management of ...www.pharmiweb.com › press-release
www.pharmiweb.com
· Konrad Werhahn, Global Head Epilepsy Medical Affairs at UCB. Alongside the presentation of these data, UCB will be facilitating two ...
DataCite Search
search.datacite.org
... file 1: of Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Bernd Pohlmann-Eden, Anthony Marson, Matthias Noack-Rink, Francisco Ramirez, Azita Tofighy, Konrad Werhahn, ...
DataCite Search
search.datacite.org
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Bernd Pohlmann-Eden, Anthony Marson, Matthias Noack-Rink, Francisco Ramirez, Azita Tofighy, Konrad Werhahn, Imane Wild ...
Vascular precursor epilepsy — Old wine in new skins?
www.infona.pl
more. COLLAPSE. Eugen Trinka, Günter Krämer, Konrad Werhahn, E. Trinka, G. Kramer, K. Werhahn ... Konrad Werhahn. UCB Biosciences ...
Alle Infos zum Namen "Konrad Werhahn"
sortiert nach Relevanz / Datum